
|Articles|July 15, 2006
Prophylactic, therapeutic use of mitomycin-C considered safe
Literature review shows single application of low-dose MMC can prevent, treat haze after surface procedures
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Pickleball, fireworks, eyecare in space, and IRIS registry data among lead stories from day 1 of AAO 2025
2
Preclinical study suggests synaptic regeneration may offer new pathway to treat glaucoma
3
Tensions rise between STAAR and Broadwood as proposed Alcon deal nears vote
4
AAO 2025: The outcomes of the VERONA and DAVIO-2 studies set up continued phase 3 research
5